WTIM
ABBV icon

Wilmington Trust Investment Management’s AbbVie ABBV Stock Holding History

Wilmington Trust Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$2M Sell
35,406
-1,200
-3% -$63K 0.41% 40
2014
Q1 		$1.88M Buy
36,606
+8,800
+32% +$445K 0.38% 50
2013
Q4 		$1.47M Sell
27,806
-1,300
-4% -$63.9K 0.29% 57
2013
Q3 		$1.3M Hold
29,106
– – 0.27% 62
2013
Q2 		$1.2M Buy
+29,106
New +$1.27M 0.26% 65

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wilmington Trust Investment Management's ABBV Position: Q2 2014 in Review

Wilmington Trust Investment Management reduced its AbbVie (ABBV) stake by 3.3% in Q2 2014, selling an estimated $63K and leaving 35,406 shares worth $2M. The position accounts for 0.41% of the portfolio, ranked #40.

Wilmington Trust Investment Management first reported a position in ABBV in Q2 2013 and has held it in 5 quarters since. 1,457 funds tracked by Wall St. Rank hold ABBV as of Q2 2014.

  • Wilmington Trust Investment Management held 35,406 shares of AbbVie worth $2M as of Q2 2014.
  • Wilmington Trust Investment Management sold 1,200 AbbVie shares in Q2 2014, an estimated $63K.
  • AbbVie made up 0.41% of Wilmington Trust Investment Management's portfolio in Q2 2014, its #40 holding.
  • Wilmington Trust Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 5 quarters since.
  • 1,457 funds tracked by Wall St. Rank held AbbVie as of Q2 2014.

Based on Wilmington Trust Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.